The activation of plasminogen by Hageman factor (Factor XII) and Hageman factor fragments.

Activation of plasminogen through surface-mediated reactions is well recognized. In the presence of kaolin, purified Hageman factor (Factor XII) changed plasminogen to plasmin, as assayed upon a synthetic amide substrate and by fibrinolysis. Kinetic studies suggested an enzymatic action of Hageman factor upon its substrate, plasminogen. Hageman factor fragments, at a protein concentration equivalent to whole Hageman factor, activated plasminogen to a lesser extent. These protein preparations were not contaminated with other agents implicated in surface-mediated fibrinolysis. Diisopropyl fluorophosphate treatment of plasminogen did not inhibit its activation by Hageman factor. These studies indicate that Hageman factor has a hitherto unsuspected function, the direct activation of plasminogen.

[1]  H. Saito,et al.  Plasma thromboplastin antecedent (PTA, factor XI): a specific and sensitive radioimmunoassay. [/sup 125/I tracer technique] , 1977 .

[2]  A. Kaplan,et al.  The Hageman Factor Dependent Pathways of Coagulation, Fibrinolysis, and Kinin-Generation , 1976, Seminars in thrombosis and hemostasis.

[3]  R. Waldmann,et al.  Fitzgerald factor (high molecular weight kininogen) clotting activity in human plasma in health and disease in various animal plasmas. , 1976, Blood.

[4]  K. Robbins,et al.  Plasminogen and plasmin. , 1976, Methods in enzymology.

[5]  C. Kluft.  Occurrence of C1 inactivator and other proteinase inhibitors in euglobulin fractions and their influence on fibrinolytic activity. , 1976, Haemostasis.

[6]  R. Waldmann,et al.  Fitzgerald Trait DEFICIENCY OF A HITHERTO UNRECOGNIZED AGENT , FITZGERALD FACTOR , PARTICIPATING IN SURFACE-MEDIATED REACTIONS OF CLOTTING , FIBRINOLYSIS , GENERATION OF KININS , AND THE PROPERTY OF DILUTED PLASMA ENHANCING VASCULAR PERMEABILITY ( PF / DIL ) , 2022 .

[7]  C. Cochrane,et al.  Structural changes accompanying enzymatic activation of human Hageman factor. , 1974, The Journal of clinical investigation.

[8]  O. Ratnoff,et al.  Defective Activation of Clotting, Fibrinolytic, and Permeability‐Enhancing Systems in Human Fletcher Trait Plasma , 1974, Circulation research.

[9]  K. Laake,et al.  Factor XII-induced fibrinolysis: studies on the separation of prekallikrein, plasminogen proactivator, and factor XI in human plasma. , 1974, Thrombosis research.

[10]  A. Kaplan,et al.  Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation. , 1974, The Journal of clinical investigation.

[11]  O. Ratnoff,et al.  Partial purification of plasma thromboplastin antecedent (factor XI) and its activation by trypsin. , 1973, The Journal of clinical investigation.

[12]  K. Austen,et al.  THE FIBRINOLYTIC PATHWAY OF HUMAN PLASMA , 1972, Journal of Experimental Medicine.

[13]  C. Forbes,et al.  Studies on plasma thromboplastin antecedent (factor XI), PTA deficiency and inhibition of PTA by plasma: pharmacologic inhibitors and specific antiserum. , 1972, The Journal of laboratory and clinical medicine.

[14]  D. Deutsch,et al.  Plasminogen: Purification from Human Plasma by Affinity Chromatography , 1970, Science.

[15]  C. Forbes,et al.  Studies on a complex mechanism for the activation of plasminogen by kaolin and by chloroform: the participation of Hageman factor and additional cofactors. , 1969, The Journal of clinical investigation.

[16]  R. Colman,et al.  Activation of plasminogen by human plasma kallikrein. , 1969, Biochemical and biophysical research communications.

[17]  C. Haanen,et al.  Purification of Activated Bovine Hageman Factor , 1963, Thrombosis and Haemostasis.

[18]  E. Davie,et al.  The purification of activated Hageman factor (activated factor XII). , 1962, Biochemistry.

[19]  S. G. Iatridis,et al.  Effect of Surface and Hageman Factor on the Endogenous or Spontaneous Activation of the Fibrinolytic System , 1961, Thrombosis and Haemostasis.

[20]  S. Niewiarowski,et al.  Rôle du Facteur Contact (Facteur Hageman) dans la Fibrinolyse , 1959, Thrombosis and Haemostasis.

[21]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.